Brief: Ascentage Pharma Group International Posts HY Net Loss Was RMB590.8 Million
21/08/2025 02:31
Aug 21 (Reuters) - Ascentage Pharma Group International 6855.HK: HY NET LOSS WAS RMB590.8 MILLION HY REVENUE RMB233.7 MILLION Further company coverage: 6855.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up